University of Virginia Health System

Thanks to a generous grant from the Pfizer Foundation, the Pfizer Initiative in International Health at the University of Virginia is striving to build resources, resolve and capacity to meet some of the most grave global health care challenges.

The Pfizer Initiative, under the direction of Dr. W. Michael Scheld, is advancing a dynamic exchange program of post-doctoral fellows and students between UVa and several international partners to conduct research of global health issues. The deadline for the next round of applications is September 1. Click here for details.

The major purpose of this program is to foster and enhance bidirectional research training for treating infectious diseases such as HIV/AIDS, tuberculosis and malaria. The Pfizer Initiative also builds on the research and administrative infrastructure of UVa's Center for Global Health. 

With the inspiration of Pfizer-supported efforts such as the Academic Alliance for AIDS Care and Prevention in Africa and the leadership of AAF member Dr. Scheld, international and UVa-based fellows are finding the drive and the resources to make an impact on the struggle to treat and prevent devastating infectious diseases. The connection of talented researchers with unique insight into the cost and debilitation of disease in the developing world and the resource-rich environment of the University of Virginia enables highly developed and highly relevant research training.

Click here for the latest news and information about HIV/AIDS, tuberculosis and maralia from the Kaiser Family Foundation with major support from the Bill & Melinda Gates Foundation



View the 2006 Pfizer Initiative in International Health
Annual Report

 
2007 Annual CGH Symposium: Global Health in a Globalized World
 Keynote Speaker Yale University,
Michele Barry, MD, FACP
Tentative Schedule